Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

66.7%

2 terminated/withdrawn out of 3 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02358733Not ApplicableTerminated

Use of IMSI in Poor Responders to IVF

Role: lead

NCT02359695Phase 1Completed

Low-dose GH Supplementation Increases Clinical Pregnancy Rate

Role: lead

NCT01842178Not ApplicableWithdrawn

Endometrial Scratching in In Vitro Fertilization Cycles With Oocyte Donation

Role: lead

All 3 trials loaded